SAUDIBIO facility is the first & only GMP biotech manufacturing site in the kingdom of Saudi Arabia


NOVO NORDISK is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. NOVO NORDISK and SAUDIBIO have signed license, supply and quality agreements for local manufacturing of insulin and haemophilia products.

SANDOZ (A Novartis Division)

SANDOZ - A Division of Novartis group, is a global leader in generic pharmaceuticals and biosimilars. SANDOZ & SAUDIBIO have signed localization agreement for selected biosimilars products.


GLENMARK is a leading integrated research-based, global pharmaceutical company and it is the first company in India has received approval from DCGI to manufacture & market an oral antiviral drug Fabiflu (Favipiravir) for use in mild to moderate COVID-19 treatment. GLENMARK and SAUDIBIO have signed license, supply and quality agreements of selected branded generics including favipiravir.

The Power of Localization

Protect prices of the products in scope for local manufacturing in the private market from further price reduction, effective from the date of local manufacturing agreement. Confirm upto 5 years supply quantities (Subject to authority approval). Guarantee price preference for the localized products in the non allocated quantities. Secure Fast Track Approvals with SFDA if Local manufacturing agreement provided

SAUDIBIO - The Perfect partner for your Business!

SAUDIBIO, a GMP certified facility is the first approved to manufacture Insulin & Biologics in the Kingdom of Saudi Arabia. Our experience and focus on biologics & biosimilars in the local market, regulatories and other government authorities enabled us the partner of choice to many business partners.

For More Information